Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study.

Saved in:
Bibliographic Details
Title: Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study.
Authors: Sundy JS (AUTHOR), Becker MA (AUTHOR), Baraf HSB (AUTHOR), Barkhuizen A (AUTHOR), Moreland LW (AUTHOR), Huang W (AUTHOR), Waltrip RW II (AUTHOR), Maroli AN (AUTHOR), Horowitz Z (AUTHOR), Pegloticase Phase 2 Study Investigators (CORPORATE AUTHOR)
Source: Arthritis & Rheumatism. Sep2008, Vol. 58 Issue 9, p2882-2891. 10p.
Database: Academic Search Ultimate
Description
ISSN:00043591
DOI:10.1002/art.23810